Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukiko Iwasaki is active.

Publication


Featured researches published by Yukiko Iwasaki.


Bioorganic & Medicinal Chemistry Letters | 2003

Novel synthesis of 2-Substituted 19-norvitamin D A-ring phosphine oxide from d-glucose as a building block

Masato Shimizu; Yukiko Iwasaki; Yoshinori Shibamoto; Miki Sato; Hector F. DeLuca; Sachiko Yamada

19-norvitamin D A-ring phosphine oxide 5 was synthesized by a new sequence mode starting from D-glucose as a chiral template. Transformation of the pyranoside ring into the A-ring carbocycle was achieved by the Pd-catalyzed Ferrier rearrangement. The phosphine oxide 5 was obtained in an 18% overall yield by this novel cost-effective method.


The Journal of Steroid Biochemistry and Molecular Biology | 2004

Two-dimensional alanine scanning mutational analysis of the interaction between the vitamin D receptor and its ligands: studies of A-ring modified 19-norvitamin D analogs☆☆☆

Masato Shimizu; Keiko Yamamoto; Mika Mihori; Yukiko Iwasaki; Daisuke Morizono; Sachiko Yamada

To clarify the structure-function relationship (SFR) of vitamin D analogs in terms of their interaction with the vitamin D receptor (VDR), we have proposed a new approach, two-dimensional alanine scanning mutational analysis (2D-ASMA). In this paper, attention was focused on the interactions around the A-ring of vitamin D. For this purpose, we synthesized four new 2-substituted 19-norvitamin D derivatives (3-6). The VDR affinity (3-6: 1, 5, 2 and 1/140, respectively) and transcriptional activity (3-6: 10, 30, 2 and 0.3, respectively) of the four compounds were evaluated relative to 1,25-(OH)(2)D(3) (5) (normalized to 1). Then, the transcriptional activities of wild-type and 18 mutant VDRs induced by the four compounds (3-6) were investigated. The results of this 18 x 4 2D-ASMA were presented as a patch table, and the effects of the mutations were analyzed in comparison with the natural hormone (1) and 2-methylene-19-nor-20-epi-1,25-(OH)(2)D(3) (2MD, 2). Of the four A-ring analogs, the 2alpha-hydroxyethoxy derivative (3) showed striking differences in the pattern on the patch table. From the results, we suggest a docking mode of this compound (3) in which the A-ring adopts the alpha conformation.


Tetrahedron Letters | 1999

4,4-Difluoro-1α,25-dihydroxyvitamin D3: Analog to probe A-ring conformation in vitamin D-receptor complex

Masato Shimizu; Yukiko Iwasaki; Sachiko Yamada

Abstract 4,4-Difluoro-1α,25-dihydroxyvitamin D 3 was synthesized from ergosterol and analysis of its 19 F NMR showed it to be a useful probe to analyze the receptor-bound A-ring conformation of vitamin D.


Tetrahedron Letters | 1996

Regioselective synthesis of 19-fluorovitamin D via fluorination of vitamin D-sulfur dioxide adducts

Yukiko Iwasaki; Masato Shimizu; Takayuki Hirosawa; Sachiko Yamada

Abstract 19-Fluorovitamin D derivatives are conveniently synthesized by the regioselective electrophilic fluorination of vitamin D-SO 2 adducts followed by desulfonylation and photochemical isomerization.


Journal of Chromatography B: Biomedical Sciences and Applications | 1995

Determination of 25-hydroxyvitamin D3 in human plasma using a non-radioactive tetranorvitamin D analogue as an internal standard

Masato Shimizu; Yukiko Iwasaki; Hiroki Ishida; Sachiko Yamada

A convenient non-radioactive method for assaying plasma 25-hydroxyvitamin D3 is described. The method uses 22-hydroxytetranorvitamin D3 as an internal standard and includes two-step liquid- and solid-phase extractions and quantification by normal-phase HPLC. The intra- and inter-assay coefficients of variation were 2.2% and 2.4%, respectively, and the analytical recovery of 25-hydroxyvitamin D3 added to plasma was quantitative. Assay linearity was obtained in the range 0.5-4.0 ml of plasma. When compared with the method employing a radioactive 25-hydroxyvitamin D3 tracer, the correlation coefficient was 0.990 (slope 0.999 and intercept 1.19 ng/ml).


Steroids | 2006

Isolation and identification of 2α,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3

Koji Takeda; Kaichiro Kominato; Atsuko Sugita; Yukiko Iwasaki; Mika Shimazaki; Masato Shimizu

Pseudonocardia autotrophica converted Vitamin D(3) to 25-hydroxyvitamin D(3) and 1alpha,25-dihydroxyvitamin D(3). The hydroxylation of Vitamin D(3) with P. autotrophica was enhanced by the addition of cyclodextrin. In this microbial hydroxylation, a new Vitamin D(3) metabolite was observed in the reaction mixture of P. autotrophica and Vitamin D(3), and was isolated in a pure form by several steps of chromatography. The structure of the new metabolite was determined to be 2alpha,25-dihydroxyvitamin D(3) by UV, NMR and mass spectroscopic analyses. Biological evaluation of the new metabolite was conducted by means of several experiments.


Tetrahedron Letters | 1994

Reaction of geometrical isomers of retinoic acid with 1,2,4-triazoline-3,5-dione having fluorescent chromophore

Masato Shimizu; Kyoko Yaguchi; Yukiko Iwasaki; Sachiko Yamada

Abstract Reactions of 1,2,4-triazoline-3,5-dione having fluorescent chromophore (DMEQ-TAD) with 9 Z -, 11 Z -, 13 Z -, and 11 Z , 13 Z -isomers of retinoic acid were studied. Except for the 9 Z -isomer, the reactions gave the 7,10-adducts in high selectivity while 9 Z -isomer gave only th 5,8,11,14-bis adducts. Interesting self-sensitized photochemical isomerizations of these adducts and the mechanism of the addition reactions are discussed.


Bone | 2007

New 19-nor-(20S)-1α,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro

Masahiro Sato; Yuko Nakamichi; Midori Nakamura; Nobuaki Sato; Tadashi Ninomiya; Akinori Muto; Hiroaki Nakamura; Hidehiro Ozawa; Yukiko Iwasaki; Emi Kobayashi; Masato Shimizu; Hector F. DeLuca; Naoyuki Takahashi; Nobuyuki Udagawa


Journal of Organic Chemistry | 1995

Syntheses of 1-Alkyl-1,25-dihydroxyvitamin D3

Hiroki Ishida; Masato Shimizu; Keiko Yamamoto; Yukiko Iwasaki; Sachiko Yamada; Kentaro Yamaguchi


Bioorganic & Medicinal Chemistry Letters | 2005

New derivatives of 1α,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity

Masato Shimizu; Yukiko Iwasaki; Mika Shimazaki; Youhei Amano; Keiko Yamamoto; Wolfgang Reischl; Sachiko Yamada

Collaboration


Dive into the Yukiko Iwasaki's collaboration.

Top Co-Authors

Avatar

Masato Shimizu

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiko Yamamoto

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hiroki Ishida

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Mika Shimazaki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Hector F. DeLuca

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Akiko Ohno

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Akinori Muto

Matsumoto Dental University

View shared research outputs
Top Co-Authors

Avatar

Atsuko Sugita

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Daisuke Morizono

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge